Paper31888
Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian livers.
Ahmed NK and 2 others. Biochem Pharmacol, 1978. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian livers. Papers, record 31888. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31888
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Ketone Oxidoreductases | Major topic |
| Liver | Major topic |
| Adult | |
| Animals | |
| Chromatography, DEAE-Cellulose | |
| Chromatography, Gel | |
| Daunorubicin | |
| Doxorubicin | |
| Humans | |
| Hydrogen-Ion Concentration | |
| In Vitro Techniques | |
| Isoelectric Focusing | |
| Male | |
| Mice | |
| Mice, Inbred DBA | |
| Rabbits | |
| Rats | |
| Species Specificity |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19016765 | CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients. | Cancer Sci | 2008 | https://conductscience.org/library/papers/19016765 | PubMed |
| 18253799 | Salivary amylase induction by tannin-enriched diets as a possible countermeasure against tannins. | J Chem Ecol | 2008 | https://conductscience.org/library/papers/18253799 | PubMed |
| 11592776 | Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11592776 | PubMed |
| 7805179 | Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7805179 | PubMed |
| 7030310 | Kinetic studies of the mechanism of pig kidney aldehyde reductase. | Biochem J | 1981 | https://conductscience.org/library/papers/7030310 | PubMed |
| 6958392 | Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6958392 | PubMed |
| 3891121 | Uptake and metabolism of daunorubicin by human myelocytic cells. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3891121 | PubMed |
| 3539383 | Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3539383 | PubMed |
| 3472675 | Comparative metabolism and elimination of adriamycin and 4'-epiadriamycin in the rat. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3472675 | PubMed |
| 3168142 | Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3168142 | PubMed |
| 1989661 | Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1989661 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31888
GET https://conductscience.org/api/papers/v1/31888/authors